Verapamil-induced	verapamil-induced	O	O
carbamazepine	carbamazepine	O	O
neurotoxicity	neurotoxicity	O	S_disease
.	.	O	O

A	a	O	O
report	report	O	O
of	of	O	O
two	two	O	O
cases	cases	O	O
.	.	O	O

Two	two	O	O
patients	patients	O	O
with	with	O	O
signs	signs	O	O
of	of	O	O
carbamazepine	carbamazepine	O	O
neurotoxicity	neurotoxicity	O	S_disease
after	after	O	O
combined	combined	O	O
treatment	treatment	O	O
with	with	O	O
verapamil	verapamil	S_chemicals	O
showed	showed	O	O
complete	complete	O	O
recovery	recovery	O	O
after	after	O	O
discontinuation	discontinuation	O	O
of	of	O	O
the	the	O	O
calcium	calcium	S_chemicals	O
entry	entry	O	O
blocker	blocker	O	O
.	.	O	O

Use	use	O	O
of	of	O	O
verapamil	verapamil	S_chemicals	O
in	in	O	O
combination	combination	O	O
with	with	O	O
carbamazepine	carbamazepine	O	O
should	should	O	O
either	either	O	O
be	be	O	O
avoided	avoided	O	O
or	or	O	O
prescribed	prescribed	O	O
only	only	O	O
with	with	O	O
appropriate	appropriate	O	O
adjustment	adjustment	O	O
of	of	O	O
the	the	O	O
carbamazepine	carbamazepine	O	O
dose	dose	O	O
(	(	O	O
usually	usually	O	O
reduction	reduction	O	O
of	of	O	O
the	the	O	O
carbamazepine	carbamazepine	O	O
dose	dose	O	O
by	by	O	O
one	one	O	O
half	half	O	O
)	)	O	O
.	.	O	O

